COURTNEY REYNOLDS: Open Payments
NPI 1477229102 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 20 payments from 10 companies in 2025. Trend: 2023 $25 · 2024 $0 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $138 |
| Actelion Pharmaceuticals US, Inc. | 3 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $51 |
| Medtronic, Inc. | 2 | $48 |
| Amgen Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: OPSUMIT, LEQVIO, LifeVest, PLASMABLADE(TM), REPATHA, SAPIEN 3 Ultra RESILIA, RENASYS TOUCH, WAINUA.
Industry payments across TX — which companies pay providers there.
